The sterol C-24 methyltransferase encoding gene, erg6 , is essential for viability of Aspergillus species

Jinhong Xie,Jeffrey M. Rybak,Adela Martin-Vicente,Xabier Guruceaga,Harrison I. Thorn,Ashley V. Nywening,Wenbo Ge,Josie E. Parker,Steven L. Kelly,P. David Rogers,Jarrod R. Fortwendel
DOI: https://doi.org/10.1038/s41467-024-48767-3
IF: 16.6
2024-05-21
Nature Communications
Abstract:Triazoles, the most widely used class of antifungal drugs, inhibit the biosynthesis of ergosterol, a crucial component of the fungal plasma membrane. Inhibition of a separate ergosterol biosynthetic step, catalyzed by the sterol C-24 methyltransferase Erg6, reduces the virulence of pathogenic yeasts, but its effects on filamentous fungal pathogens like Aspergillus fumigatus remain unexplored. Here, we show that the lipid droplet-associated enzyme Erg6 is essential for the viability of A. fumigatus and other Aspergillus species, including A. lentulus , A. terreus , and A. nidulans. Downregulation of erg6 causes loss of sterol-rich membrane domains required for apical extension of hyphae, as well as altered sterol profiles consistent with the Erg6 enzyme functioning upstream of the triazole drug target, Cyp51A/Cyp51B. Unexpectedly, erg6 -repressed strains display wild-type susceptibility against the ergosterol-active triazole and polyene antifungals. Finally, we show that erg6 repression results in significant reduction in mortality in a murine model of invasive aspergillosis. Taken together with recent studies, our work supports Erg6 as a potentially pan-fungal drug target.
multidisciplinary sciences
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to determine the survival importance of the gene encoding sterol C - 24 methyltransferase (*erg6*) in Aspergillus fumigatus and other Aspergillus species. Specifically, the study aims to explore whether the loss of function of the *erg6* gene will affect the viability of these fungi and what the specific mechanism of this effect is. ### Research Background Aspergillus fumigatus is an important pathogenic fungus that can cause invasive aspergillosis (IA), a fungal infection with a high mortality rate. Currently, antifungal drugs used to treat IA mainly include triazoles, polyenes, and echinocandins. However, the clinical effects of these drugs are affected by host toxicity, side effects, and low bioavailability, and the global resistance to triazole drugs is increasing, making long - term treatment more complicated. ### Research Objectives 1. **Verify the survival importance of the *erg6* gene in Aspergillus fumigatus**: - By constructing *erg6* gene knockout mutants, study its impact on the viability of Aspergillus fumigatus. - Further verify the importance of the *erg6* gene at different growth stages through conditional expression systems (such as the tetracycline - inducible system). 2. **Explore the general importance of the *erg6* gene in other Aspergillus species**: - Construct similar conditional expression systems in other Aspergillus species to verify whether the function of the *erg6* gene is universal. 3. **Analyze the changes in cell membrane components after the loss of function of the *erg6* gene**: - Analyze the changes in sterol components in the cell membrane, especially the content changes of ergosterol and lanosterol, through fluorescence staining and gas chromatography - mass spectrometry (GC - MS). 4. **Evaluate the impact of the loss of function of the *erg6* gene on drug sensitivity**: - Detect the changes in the sensitivity of Aspergillus fumigatus to existing antifungal drugs (especially drugs targeting ergosterol) after the loss of function of the *erg6* gene. ### Main Findings - The *erg6* gene is essential in Aspergillus fumigatus, and its loss of function will lead to severe growth defects and cell death. - The *erg6* gene also shows similar importance and function in other Aspergillus species. - The loss of function of the *erg6* gene leads to a significant decrease in the ergosterol content in the cell membrane and a large accumulation of lanosterol. - The loss of function of the *erg6* gene does not change the sensitivity of Aspergillus fumigatus to existing antifungal drugs. - In the mouse model of invasive aspergillosis, the loss of function of the *erg6* gene significantly reduces the mortality rate. ### Conclusion The research results support the *erg6* gene as a potential pan - fungal drug target, providing a theoretical basis for the development of new antifungal drugs.